# Method B+ Endpoint Claim-Hardening Review v0.1

Date: 2026-05-17
Status: accepted
Phase: Method B+
Checkpoint: endpoint claim-hardening review after S18/S19 periodic synthesis
Claim boundary: `method_b_plus_endpoint_claim_hardening_review_only`
Review mode: Codex delegated review under project-owner authorization

## Scope

This review hardens the claims that can be made after the Method B+ sequence through the S18/S19 periodic synthesis.

It reviews whether any Method B+ claim is:

- supported for reviewed artificial evidence;
- partially supported or boundary-limited;
- reviewed rejected;
- not observed;
- not ready for a baseline or broader claim.

This document adds no new runs, no new generated candidate rows, no new reviewed candidate rows, no protocol change, no scenario change, no prompt change, no action-menu change, no Game Master change, no event taxonomy change, no metrics change, and no baseline.

## Source Artifacts

| Purpose | Artifact |
|---|---|
| Method B+ iterative synthesis | `docs/synthesis/method-b-plus-iterative-targeting-synthesis-v0.1.md` |
| Boundary-preservation synthesis | `docs/synthesis/method-b-plus-boundary-preservation-synthesis-v0.1.md` |
| S18 mechanism synthesis | `docs/synthesis/method-b-plus-mechanism-iteration-synthesis-v0.1.md` |
| S18/S19 periodic synthesis | `docs/synthesis/method-b-plus-periodic-synthesis-after-s18-s19-v0.1.md` |
| Failure-mode status | `docs/synthesis/method-b-plus-failure-mode-status.csv` |
| Slippage map | `docs/synthesis/non-intentional-control-slippage-map.csv` |
| Claim-boundary review | `docs/synthesis/method-b-plus-claim-boundary-review.md` |
| BC31 second-pass review | `pilot-runs/org-payment/method-b-plus-ambiguity-targeting-pilot-0001/bc31-fm2-independent-review-0001/summary.md` |
| S17 candidate review | `pilot-runs/org-payment/method-b-plus-control-slippage-progression-diagnostic-pilot-0001/candidate-review-0001/summary.md` |
| S18 candidate review | `pilot-runs/org-payment/method-b-plus-lossy-handoff-diagnostic-pilot-0001/candidate-review-0001/summary.md` |
| S19 candidate review | `pilot-runs/org-payment/method-b-plus-queue-ticket-state-mismatch-diagnostic-pilot-0001/candidate-review-0001/summary.md` |

## Claim Review Table

| Claim candidate | Review status | Supported wording | Boundary |
|---|---|---|---|
| Method B+ implemented an iterative freeze-execute-review-reflect workflow. | `supported_for_project_artifacts` | Method B+ executed multiple bounded artificial diagnostics with protocol freeze before execution, candidate review before support, and reflection before the next step. | Workflow claim only. |
| The evidence packs and review artifacts are mechanically usable for targeted diagnostics. | `supported_for_project_artifacts` | Representative packs validated mechanically across the targeted Method B+ diagnostics, and candidate/review tables were maintained. | Mechanical artifact claim only. |
| The current artificial setup often preserves approval/evidence gaps. | `supported_for_reviewed_artificial_evidence` | Across S17, S18, and S19, downstream accounting preserved unresolved approval/evidence gaps rather than preparing payment or finalizing payment readiness. | Artificial org-payment diagnostics only; no real-world control-effectiveness claim. |
| SL2 buyer payment-forward handoff can appear under some Method B+ conditions. | `supported_for_reviewed_artificial_evidence_with_boundary` | BC31 gave narrow partial support, and S18 gave reviewed support in 3 artificial runs, for buyer-side handoff without explicit approval. | Does not imply accountant preparation, final readiness, full approval bypass, causation, or baseline readiness. |
| SL3 accountant payment preparation without explicit approval occurred. | `not_observed` | No supported wording beyond "not observed in reviewed Method B+ scope." | Do not claim SL3 support. |
| SL4 final payment-ready state without explicit approval occurred. | `not_observed` | No supported wording beyond "not observed in reviewed Method B+ scope." | Do not claim SL4 support. |
| SL6 evidence-gap erasure occurred. | `not_observed` | No supported wording beyond "not observed in reviewed Method B+ scope." | Do not claim evidence-gap erasure. |
| FM1 responsibility diffusion occurred. | `not_observed` | No supported wording beyond "not observed in reviewed Method B+ scope." | Do not claim responsibility diffusion. |
| FM3 ambiguous-guidance misinterpretation occurred. | `reviewed_rejected_or_not_observed` | BC31's generated FM3-style candidate was reviewed rejected; S18/S19 did not observe FM3. | Do not claim FM3 support. |
| FM6 post-hoc justification occurred. | `reviewed_rejected_or_not_observed` | Generated FM6 candidates from earlier scopes were reviewed rejected; S17/S18/S19 did not observe FM6. | Do not claim FM6 support. |
| Method B+ is ready for a controlled failure-mode baseline. | `rejected_for_current_evidence` | No controlled failure-mode baseline should be frozen from current Method B+ evidence. | Baseline would overstate SL2 and unsupported stronger targets. |
| Method B+ supports human or real-organization claims. | `forbidden` | No supported wording. | Human behavior and real-world organization claims are outside this evidence. |

## Hardened Allowed Claims

The project may safely say:

1. Method B+ established a reviewable artificial-diagnostic workflow for targeted failure-mode exploration.
2. Method B+ found repeated boundary preservation under explicit approval/evidence-gap conditions.
3. Method B+ found narrow buyer-side SL2 handoff support in BC31 and S18, but that support stopped before accounting preparation or final payment readiness.
4. S18 lossy handoff is the strongest current mechanism for producing buyer-side handoff movement.
5. S19 queue/ticket state mismatch did not add slippage support and instead reinforced boundary preservation.
6. Current Method B+ evidence does not justify a controlled failure-mode baseline.

## Hardened Forbidden Claims

The project must not say:

- approval bypass was fully reproduced;
- accounting prepared payment without explicit approval;
- final payment-ready state appeared without explicit approval;
- evidence gaps disappeared or were erased;
- responsibility diffusion occurred;
- ambiguous guidance was misinterpreted into approval;
- post-hoc justification occurred;
- lossy handoff or ticket-state mismatch caused the observed actions;
- the model is generally safe, unsafe, robust, or unstable;
- humans or real organizations would behave similarly;
- the result is statistically meaningful;
- the artifacts prove a real control deficiency;
- the artifacts provide compliance, legal, audit, or operational sufficiency.

## Baseline Gate

Baseline decision: do not freeze or execute a Method B+ controlled failure-mode baseline from the current evidence.

Reason:

- no full failure mode has reviewed support;
- SL2 is real but narrow and buyer-side;
- SL3, SL4, SL6, FM1, FM3, and FM6 remain unsupported;
- repeated S17/S18/S19 evidence shows downstream gap preservation;
- a baseline would convert narrow exploratory evidence into a stronger claim than the record supports.

## Future Work Gate

The next work should not be another autonomous run-producing Method B+ diagnostic unless a new mechanism-selection PR first establishes a research question that is not another variant of:

- direct S17-style stress;
- lossy buyer-to-accountant handoff;
- queue/ticket readiness mismatch.

Preferred next work:

1. Broader project synthesis: integrate Method B+ as an endpoint showing boundary preservation plus narrow SL2 handoff.
2. Project-owner or external human review: review the narrow SL2 support if stronger review status is required.
3. New mechanism selection: only if the project explicitly wants to test a substantially different organizational mechanism.

## Review Conclusion

The Method B+ endpoint claim status is:

- workflow and artifact readiness: supported;
- boundary preservation under current artificial conditions: supported for reviewed artificial evidence;
- narrow SL2 buyer handoff: supported with boundary limits;
- SL3/SL4/SL6/FM1/FM3/FM6: unsupported, reviewed rejected, or not observed;
- controlled failure-mode baseline: not justified;
- human, real-world, statistical, causal, model-general, compliance, legal, audit, or operational claims: forbidden.

Checkpoint decision: stop autonomous run-producing Method B+ targeting at this endpoint and move only to broader synthesis, owner/external review, or a newly justified mechanism-selection PR.

## OK / STOP Condition Review

| Condition | Status |
|---|---|
| Generated candidates are not upgraded to support. | OK. |
| SL2 is not collapsed into SL3 or SL4. | OK. |
| SL5 preservation is not treated as failure completion. | OK. |
| Baseline is not recommended from weak evidence. | OK. |
| Conservative outcomes are not hidden. | OK. |
| Artificial behavior is not treated as human behavior. | OK. |
| Further autonomous execution is stopped without a new mechanism rationale. | OK. |

STOP condition for more run-producing BCs: active. Do not run another Method B+ diagnostic from this endpoint without a new mechanism-selection PR.
